Home/Filings/4/0001127602-15-012129
4//SEC Filing

ALLERGAN INC 4

Accession 0001127602-15-012129

CIK 0000850693operating

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 7:39 PM ET

Size

9.0 KB

Accession

0001127602-15-012129

Insider Transaction Report

Form 4
Period: 2015-03-17
Transactions
  • Disposition to Issuer

    Common Stock

    2015-03-176,796.960 total
  • Exercise/Conversion

    Phantom Stock Units

    2015-03-171,189.960 total
    From: 2015-03-17Exp: 2015-03-17Common Stock (1,189.96 underlying)
  • Exercise/Conversion

    Common Stock

    2015-03-17+1,189.966,796.96 total
Footnotes (3)
  • [F1]Each phantom stock unit ("PSU") was the economic equivalent of one share of the Issuer's common stock. Each PSU settled in full on the Effective date (as define below) in connection with the reporting person's termination of service. The amount shown includes shares acquired pursuant to dividend rights attached to each PSU.
  • [F2]Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51per share on the Effective Date.
  • [F3]The number of shares reported on this line item includes shares acquired pursuant to dividend rights attached to restricted stock units that were previously granted and reported as Table 1, Non-Derivative Securities.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000850693

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:39 PM ET
Size
9.0 KB